These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 27896073)

  • 1. Medium-chain triglyceride supplementation under a low-carbohydrate formula is a promising therapy for adult-onset type II citrullinemia.
    Hayasaka K; Numakura C; Toyota K; Kakizaki S; Watanabe H; Haga H; Takahashi H; Takahashi Y; Kaneko M; Yamakawa M; Nunoi H; Kato T; Ueno Y; Mori M
    Mol Genet Metab Rep; 2014; 1():42-50. PubMed ID: 27896073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment and Pathomechanism of Citrin Deficiency].
    Hayasaka K; Numakura C; Watanabe H
    Brain Nerve; 2015 Jun; 67(6):739-47. PubMed ID: 26062589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medium-chain triglycerides supplement therapy with a low-carbohydrate formula can supply energy and enhance ammonia detoxification in the hepatocytes of patients with adult-onset type II citrullinemia.
    Hayasaka K; Numakura C; Yamakawa M; Mitsui T; Watanabe H; Haga H; Yazaki M; Ohira H; Ochiai Y; Tahara T; Nakahara T; Yamashiki N; Nakayama T; Kon T; Mitsubuchi H; Yoshida H
    J Inherit Metab Dis; 2018 Sep; 41(5):777-784. PubMed ID: 29651749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adult-onset type II citrullinemia: Current insights and therapy.
    Hayasaka K; Numakura C
    Appl Clin Genet; 2018; 11():163-170. PubMed ID: 30588060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic basis and treatment of citrin deficiency.
    Hayasaka K
    J Inherit Metab Dis; 2021 Jan; 44(1):110-117. PubMed ID: 32740958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment with lactose (galactose)-restricted and medium-chain triglyceride-supplemented formula for neonatal intrahepatic cholestasis caused by citrin deficiency.
    Hayasaka K; Numakura C; Toyota K; Kimura T
    JIMD Rep; 2012; 2():37-44. PubMed ID: 23430852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current treatment for citrin deficiency during NICCD and adaptation/compensation stages: Strategy to prevent CTLN2.
    Okano Y; Ohura T; Sakamoto O; Inui A
    Mol Genet Metab; 2019 Jul; 127(3):175-183. PubMed ID: 31255436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic derangements in deficiency of citrin, a liver-type mitochondrial aspartate-glutamate carrier.
    Saheki T; Kobayashi K; Iijima M; Moriyama M; Yazaki M; Takei Y; Ikeda S
    Hepatol Res; 2005 Oct; 33(2):181-4. PubMed ID: 16199199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetes mellitus exacerbates citrin deficiency via glucose toxicity.
    Watanabe Y; Numakura C; Tahara T; Fukui K; Torimura T; Hiromatsu Y; Tomotsune K; Yamakawa M; Hayasaka K
    Diabetes Res Clin Pract; 2020 Jun; 164():108159. PubMed ID: 32335094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondrial aspartate glutamate carrier (citrin) deficiency as the cause of adult-onset type II citrullinemia (CTLN2) and idiopathic neonatal hepatitis (NICCD).
    Saheki T; Kobayashi K
    J Hum Genet; 2002; 47(7):333-41. PubMed ID: 12111366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenesis and Management of Citrin Deficiency.
    Hayasaka K
    Intern Med; 2024 Jul; 63(14):1977-1986. PubMed ID: 37952953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exogenous aralar/slc25a12 can replace citrin/slc25a13 as malate aspartate shuttle component in liver.
    González-Moreno L; Santamaría-Cano A; Paradela A; Martínez-Chantar ML; Martín MÁ; Pérez-Carreras M; García-Picazo A; Vázquez J; Calvo E; González-Aseguinolaza G; Saheki T; Del Arco A; Satrústegui J; Contreras L
    Mol Genet Metab Rep; 2023 Jun; 35():100967. PubMed ID: 36967723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of supplementation on food intake, body weight and hepatic metabolites in the citrin/mitochondrial glycerol-3-phosphate dehydrogenase double-knockout mouse model of human citrin deficiency.
    Saheki T; Inoue K; Ono H; Katsura N; Yokogawa M; Yoshidumi Y; Furuie S; Kuroda E; Ushikai M; Asakawa A; Inui A; Eto K; Kadowaki T; Sinasac DS; Yamamura K; Kobayashi K
    Mol Genet Metab; 2012 Nov; 107(3):322-9. PubMed ID: 22921887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel mutation of the SLC25A13 gene in a Chinese patient with citrin deficiency detected by target next-generation sequencing.
    Liu G; Wei X; Chen R; Zhou H; Li X; Sun Y; Xie S; Zhu Q; Qu N; Yang G; Chu Y; Wu H; Lan Z; Wang J; Yang Y; Yi X
    Gene; 2014 Jan; 533(2):547-53. PubMed ID: 24161253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AGC2 (Citrin) Deficiency-From Recognition of the Disease till Construction of Therapeutic Procedures.
    Saheki T; Moriyama M; Funahashi A; Kuroda E
    Biomolecules; 2020 Jul; 10(8):. PubMed ID: 32722104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical manifestation and long-term outcome of citrin deficiency: Report from a nationwide study in Japan.
    Kido J; Häberle J; Sugawara K; Tanaka T; Nagao M; Sawada T; Wada Y; Numakura C; Murayama K; Watanabe Y; Kojima-Ishii K; Sasai H; Kosugiyama K; Nakamura K
    J Inherit Metab Dis; 2022 May; 45(3):431-444. PubMed ID: 35142380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth impairment in individuals with citrin deficiency.
    Numakura C; Tamiya G; Ueki M; Okada T; Maisawa SI; Kojima-Ishii K; Murakami J; Horikawa R; Tokuhara D; Ito K; Adachi M; Abiko T; Mitsui T; Hayasaka K
    J Inherit Metab Dis; 2019 May; 42(3):501-508. PubMed ID: 30715743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Slc25a13-knockout mice harbor metabolic deficits but fail to display hallmarks of adult-onset type II citrullinemia.
    Sinasac DS; Moriyama M; Jalil MA; Begum L; Li MX; Iijima M; Horiuchi M; Robinson BH; Kobayashi K; Saheki T; Tsui LC
    Mol Cell Biol; 2004 Jan; 24(2):527-36. PubMed ID: 14701727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of daily energy, protein, fat, and carbohydrate intake in citrin-deficient patients: Towards prevention of adult-onset type II citrullinemia.
    Okano Y; Okamoto M; Yazaki M; Inui A; Ohura T; Murayama K; Watanabe Y; Tokuhara D; Takeshima Y
    Mol Genet Metab; 2021 May; 133(1):63-70. PubMed ID: 33741270
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.